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Abstract
Phosphodiesterase 6 (PDE6) is a critical enzyme in the eyesight-signaling
pathway. When activated, PDE6 hydrolyzes cGMP to GMP, which deactivates cGMPgated ion channels, causing hyperpolarization of the cell and activating the sensory
neurons responsible for vision. Within the PDE family, PDE6 is the only enzyme known
to have an inhibitory subunit (PDE6-γ), which allows for the regulation of cGMP levels.
When PDE6-γ is bound to PDE6, the enzyme is turned “off” and cannot catalyze cGMP.
The α subunit of the G-protein transducin removes PDE6-γ and activates PDE6. PDE6
has proven problematic to isolate, making it difficult to study experimentally and
preventing a structure from being solved. A chimera of the homologous proteins PDE5
and PDE6 (PDE5/6) has been constructed to serve as a model for PDE6 that can be
expressed and purified. The validity of PDE5/6 as a model for PDE6 has been
demonstrated through mild inhibition by PDE6-γ. To study the native sequence of PDE6,
a computational approach was applied by creating a homology model of PDE6. Using
this model has allowed us to understand the structural basis for PDE6’s inhibition by
PDE6-γ.
We have investigated correlations in protein dynamics possibly responsible for
allosteric properties by running over 1 microsecond (µs) of molecular dynamics
simulations and carrying out various analyses. PDE6 and PDE5/6 are both inhibited by
the PDE5 inhibitor sildenafil. With this knowledge, systems of the homology model of
PDE6, PDE5, and PDE5/6 in ligand-free (apo), sildenafil bound, and PDE6-γ bound
states were constructed and simulated for 100-300 nanoseconds each. Our analyses were
aimed at evaluating the quality of our homology model of PDE6 and showing the affect
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of sildenafil and PDE6-γ within each system and across different systems. These studies
have allowed us to gain insight into the structural characteristics and the specific residues
that are involved in allosteric communication and regulation of PDE6’s inhibition by
PDE6-γ. Using RMSF and cross-correlational analyses we have discovered a novel
region that shows correlation with the H- and M-loops and could be an allosteric
therapeutic target for diseases in which PDE6 is implicated, such as retinitis pigmentosa.
Through this work, we hope to gain a greater understanding of the molecular dynamics
and mechanisms of PDE6 and how these features may relate to the molecular
underpinnings of eyesight.
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Introduction
In Madeleine L’Engle’s A Wrinkle in Time, the main character attempts to explain
vision to a species with no history of eyesight. After the conversation, the character
realizes that her perception of the world is so influenced by eyesight that she can’t even
describe the sense. Just how is it that we see? The foundation of eyesight is a series of
molecular level interactions. An integral protein in the molecular pathway that allows us
to experience eyesight is phosphodiesterase 6 (PDE6). Mutations and structural changes
in PDE6 have been implicated in diseases of the eye such as retinitis pigmentosa (RP)
and congenital night blindness. Despite the significance of PDE6 in the eyesight
signaling pathway and its relationship to diseases of the eye, it has not been very well
studied.
The goal of this project was to elucidate the role of structural dynamics in the
inhibition/activation mechanisms of PDE6 through a computational investigation. A
powerful aspect of computational biology is the use of molecular dynamics methods to
simulate molecular interactions and gain insight in ways not possible through
experimental techniques. These methods effectively allow us to use computers as
“molecular microscopes” to view molecular level interactions1. Although the groundwork
for these techniques was laid down decades ago, computer technology has just recently
progressed far enough to meet the technical specifications required of intensive
simulations, making computational biology a very exciting and emerging field. Due to
the challenges in studying PDE6 experimentally, a computational approach has the
potential to greatly increase our knowledge of this important enzyme.
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The aim of this study was to gain a thorough understanding of the structurefunction relationships and critical residues in PDE6 by carrying out molecular dynamics
simulations, dynamic cross-correlational analysis, homology modeling, and principal
component analysis on the enzyme. This knowledge will provide new insights into PDE6
function, which may help to elucidate the cause of RP and congenital night blindness as
well as give us a broader understanding of the processes that allow vision to occur.

Review of Literature
To propagate signals, cells use multi step, and often complex, signaling pathways.
Cyclic AMP (cAMP) and cyclic GMP (cGMP) are two signaling molecules that help
propagate the signals of the pathways in which they are involved. The main function of
the class of enzymes called phosphodiesterases (PDEs) is to hydrolyze cAMP and cGMP
to AMP and GMP respectively2. Given that regulation of cAMP and cGMP allows the
various enzymes downstream of cAMP and cGMP in the signaling cascade to also be
regulated, PDEs are an important class of regulatory enzymes. Due to their important
functions, they are often targeted for drug development3,4.
PDE6 is one of the eleven different types of PDEs and is found in both the rod
and cone cells of the eye2,5. One of the properties of PDE6 that makes it unique amongst
PDEs is that it has a naturally occurring inhibitory gamma (γ) subunit6,7. When the γsubunit is bound to PDE6, the enzyme is inactive and when removed PDE6 becomes
active6,7. This allows the γ-subunit to regulate the activity of PDE6. Although there are
several mechanisms by which PDEs can be inhibited, the γ-subunit is known to affect
only PDE66. Two structural features, the H-loop and the M-loop, near the binding site of
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cGMP are thought to significantly aid the γ-subunit in binding PDE68,9. PDE6 has
multiple domains and we are only studying the catalytic domain (the catalytic domain of
PDE6 alone has been shown to be functional and can be inhibited by the γ-subunit)8, 10.
The catalytic domain is a dimer of two identical subunits (αα) in cone PDE6, and the
focus of this study will be the catalytic domain monomer (α)10.

C

D
Figure 1: A) Surface representation of PDE6 model showing the catalytic pocket8. B) Surface
representation of PDE6 model highlighting the γ-subunit (dark grey) blocking access to the
catalytic pocket of PDE6. C) The reaction of cGMP to GMP catalyzed by PDE6. D) Signaling
Pathway of Eyesight Diagram11

The signaling pathway of eyesight has several steps, as shown in Figure 1D.
When light enters the eye, it interacts with the G-protein coupled receptor rhodophsin,
7

which in turn activates the G-protein transducin12. The α-subunit of transducin then
activates PDE6 by interacting with the γ-subunit and dissociating it from PDE6, allowing
PDE6 to rapidly hydrolyze cGMP to GMP12. The drop in concentration of cGMP
deactivates cGMP-gated ion channels, causing hyperpolarization of the cell. This
activates the sensory neurons responsible for vision6, 12. Mutations to residue ASN661 on
the H-loop (N661S and N661A) of PDE6 have been identified in cases of RP, indicating
this residue is critical for proper functioning8, 13.
Although PDEs are well-studied enzymes, PDE6 has not been as well
characterized as other PDEs due to the fact that it is extremely difficult to express in
bacteria. As a result, it has never been isolated and its atomic structure has not been
solved6. To work around this issue, researchers have created a ‘chimera’ of PDE5 and
PDE6, called PDE5/6. PDE5 and PDE6 are very sequentially homologous, so by
substituting the sequences unique to PDE6 for the same areas on the PDE5 gene, a hybrid
of PDE5 and PDE6 (PDE5/6) can be expressed and isolated2,6,8. The PDE5/6 has been
shown to retain the ability to hydrolyze cGMP while also being effectively inhibited by
the γ-subunit, making it a reasonable model to gain insight into PDE68. The functionality
of PDE5 and PDE5/6 differs from that of PDE6 in that the former hydrolyze cGMP with
low efficiency (~0.55 cGMP/second) while the latter hydrolyzes cGMP very efficiently
(~2000 cGMP/second)8. The structure of the PDE5/6 bound with the inhibitory drug
sildenafil and the γ-subunit has been determined by X-ray crystallography, providing a
basis for molecular modeling studies8.
Despite the advances brought about by the chimera studies, there are several
questions about PDE6 that remain unanswered. The chimera has been shown to have an
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H-loop 26 angstroms closer to the M-loop than in PDE5, even though the H-loop amino
acid sequence is exactly the same in PDE5 and the chimera8. This observation has raised
several questions, including: What structural characteristic causes this movement of the
H-loop in the chimera? Is the same H-loop configuration present in native PDE6 or is it
only observed for the chimera? What structural influence does the γ-subunit have on
PDE6? Are there any allosteric interactions occurring in PDE6? What are the structural
differences between drug bound, γ-subunit bound, and free states of PDE6? These
questions are well suited for the methods of computational biophysics, which I aim to
apply in this project.

Methods
Molecular dynamics was first applied to the study of proteins in the 1970s1, 14.
Using experimental data from physical chemistry, ‘force fields’ that describe the bonded
(i.e.- chemical bonds, bond angles, and bond dihedrals) and non-bonded (i.e.- van der
Waals forces and electrostatics) interactions between atoms were developed. In a
molecular dynamics simulation, the potential energy at every step is calculated using
these force fields for all of the atoms within the system. The software used will then take
the negative gradient of these potential energies to get the force acting on every atom. At
each time point of the simulation, the atoms are displaced along their force vector to
generate a new system configuration. This is repeated thousands of times to get a
trajectory of a desired length. The application of molecular dynamics allows us to study
proteins at the molecular level in a way not possible with traditional experimental
methods.
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To carry out my research, I used a computer running a Unix based operating
system with Gromacs software installed, and access to a High Performance Computing
(HPC) cluster. Access to a computer used for post simulation analysis was provided
through the May Lab. The BECAT center provides access to its HPC cluster (HORNET),
which was used to carry out simulations that required large amounts of memory and
processing power. The local computer and HORNET are optimized to run
computationally intensive processes. GROMACS software was used to run the
simulations with the CHARMM27 force field and TIP3P water15.
In order to simulate a protein using molecular dynamics, initial Cartesian
coordinates are needed. Most commonly, a structure file is acquired from the Protein
DataBase (pdb) where experimentally determined protein structures are deposited. In
order to study the PDE5/6 chimera, the PDE5/6 with the γ-subunit bound structure and
PDE5/6 with inhibitor sildenafil bound structure (pdb files 3JWR and 3JWQ
respectively) were selected for study. The first step taken was to remove the sildenafil
from the 3JWQ structure to get an apo PDE5/6 structure. The PDE5 structures used were
apo PDE5 and sildenafil bound PDE5 (pdb codes 2H40 and 2H42 respectively). A
homology model of PDE6 was then built with the program I-Tasser16. The sequence for
PDE6 was fed into the I-Tasser server, which then analyzed the sequence of PDE6, found
sequentially similar proteins, analyzed the structures of those proteins, and then used all
of the structural information to create a homology model of PDE6. Using the modeling
and visualization program Chimera, sildenafil and γ-bound PDE6 structures were
created17.
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All three of the PDE5/6 structures (apo, sildenafil bound, and γ-bound), the two
PDE5 structures (apo and sildenafil bound), and the PDE6 structures (apo, sildenafil
bound, γ-bound, N661S mutation, and N661A mutation) were simulated for 100nanoseconds (Figure 2). The purpose of these simulation is to allow the structures to first
reach a “relaxed” conformation, after which the equilibrium dynamics of the enzymes
can be analyzed18.

A

B

Figure 2: A.) PDE5/6 after 20 nanoseconds of the 100 nanosecond simulation, with the M-loop
shown in green and the H-loop shown in red. B.) Residue ASN661 highlighted on the H-loop

The main analyses performed on the 100ns simulation data for each system were
root mean square deviation (RMSD), root mean square fluctuation (RMSF), calculation
of H- and M-loop distances, principal component analysis (PCA), and cross correlational
analysis using the Bio3D suite19. These methods were used for validation, system
comparisons, and gaining insight into structural dynamics of the proteins.
RMSD is used to calculate how far from the starting structure the proteins’
structures deviate over the course of the simulation. RMSD was one of the tools used to
assess validity of the PDE6 homology model. The structural deviations of the model
measured by RMSD values being equal to or less than the chimera’s structural deviations
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would verify that the model can be used as an accurate representation of PDE6 for our
purposes. RMSF is used to get the fluctuations of each individual amino acid in each
protein over the course of the simulations. The overall RMSF data can be used to
understand which regions of the protein are the most or least flexible, giving insight into
structural dynamics.
The H- and M-loop distances were calculated by measuring the distance between
the center of masses (COM) between the H- and M-loops as well as the distances
between the residues on the ends of each loop (residues 668 of the H-loop and 797 of the
M-loop). Results between the COM and two residue distances were compared to see if
the two methods gave agreeable distances and to see if one method is more accurate than
the other.
The PCA and cross-correlational analysis are both aimed at getting information
about the global, correlated motions of the proteins. PCA involves building a covariance
matrix from the trajectory of each simulation, diagonalizing the matrix to get
eigenvectors and eigenvalues, and then sorting the eigenvectors by eigenvalue to find the
principal components. Each principal component accounts for a percentage of the total
positional fluctuations, or global motions, of the proteins.
Principal component analysis (PCA) will be the final tool used in piecing together
a greater understanding of the H- and M-loop interface. By taking the structures of PDE5
(pdb file 2H40), the PDE5/6 chimera, mutated PDE6 and the PDE6 homology model and
comparing them with principal component analysis, correlated global motions throughout
the proteins can be characterized20. This will help to elucidate the allosteric interactions
occurring within PDE6 that allow it, but not PDE5, to bind the γ-subunit. The mutated
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system will give us insight into what structural interactions cause decreased binding of
the γ-subunit and the implications in RP.
Collectively, these experiments will allow us to gain insight into the structural
basis for inhibition of PDE6, what structural effect mutations have, which conformations
of PDE6 are most stable, and what specific interactions within PDE6 allow inhibition by
the γ-subunit. The knowledge gleaned through my University Scholar project will add to
our knowledge of eyesight signaling pathways and help to understand how diseases such
as retinitis pigmentosa occur.
Results
Validation of Methods and Systems

Max H- and M-loop
System

Simulation Time

Max RMSD

Distance

PDE5 Apo

100 nanoseconds

3.7 Å

32.6 Å

Sildenafil Bound

100 nanoseconds

2.7 Å

31.0 Å

PDE5/6 Apo

100 nanoseconds

1.8 Å

18.1 Å

100 nanoseconds

2.0 Å

15.7 Å

100 nanoseconds

2.3 Å

15.9 Å

PDE5

with

PDE5/6

with

Sildenafil Bound
PDE5/6

with

Subunit Bound

γ-
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PDE6 Apo
PDE6

3.8 Å

12.2 Å

100 nanoseconds

3.2 Å

12.4 Å

100 nanoseconds

3.2 Å

10.9 Å

with

Sildenafil Bound
PDE6

100 nanoseconds

with

Subunit Bound

γ-

Table 1: The maximum RMSD and H- and M-loop distance for each of the systems
simulated.

Figure 3: The RMSDs for the PDE5/6, PDE5, and PDE6 apo systems over the course of 100
nanosecond simulations

The initial analyses were done in order to validate the methods and systems used.
The RMSD analysis of all of the systems was very low, with the apo systems (Figure 3)
showing a maximum RMSD value of only ~4 Å, a low RMSD. A key point to note here
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is that the RMSD of the homology model for PDE6 also matches up well with the
RMSDs of the real crystal structures. This is a strong indication that the model used is a
stable model compatible with our methods and that it is likely an accurate model of
PDE6.

H-loop
M-loop

Figure 4: RMSF of PDE5 apo and sildenafil systems after 100 nanosecond simulations.
H- and M-loop regions are highlighted.

Because PDE5 is so well studied, it was logical to see if analyses of the
simulations gave results that match up well with the knowledge gained from experimental
studies. Sildenafil is a known potent inhibitor of PDE5 and therefore the expectation is
that the analyses run on the PDE5 apo and sildenafil bound simulations would show that
sildenafil causes decreased flexibility, indicating it is a tightly bound inhibitor and would
prevent conversion of cGMP. The RMSF data for the PDE5 apo and sildenafil bound
simulations (Figure 4) shows that the H- and M-loops of PDE5 apo show very high
flexibility, matching what previous experimental studies showed21. The RMSF of
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sildenafil bound PDE5 shows very reduced flexibility in the H- (residues 126 to 149) and
M- (residues 254 to 277) loops, with the RMSFs going from ~5 Å to ~2.5 Å for the Hloop and ~3.5 Å to ~2 Å for the M-loop. These large reductions in the flexibility of these
regions is in line with the idea that a potent inhibitor such as sildenafil reduces enzyme
flexibility and could give insight into the long range effects of sildenafil binding. The
PCA of the PDE5 apo and sildenafil bound simulations allows for further investigation.
The apo simulation clearly shows that the system samples a large conformational space.
The sildenafil bound simulation shows that the motions of the protein are severely
restricted in comparison, with the system only sampling a small portion that the apo
system samples. Taken together, these two analyses are very strong validations of the
methods we used. The sildenafil bound PDE5 simulation shows reduced flexibility in
highly flexible regions (the H- and M-loops) and reduced motions overall of the system.
Reduced flexibility and motion are indicative of strong inhibition, which was expected.

A

B

H-loop

M-loop

Figure 5: A) Principal component analysis of PDE5/6 apo, PDE5/6 with sildenafil bound, and
PDE5/6 with the PDE6 γ-subunit bound. B) RMSF of the PDE5/6 systems after 100 nanosecond
simulations

Further validation was done through PCA of data of all of the PDE5/6 simulations
(Figure 5a). The apo system shows a large conformational space being sampled, whereas
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the sildenafil bound system samples a smaller portion of the conformational space
sampled by the apo system. This shows, just as was the case with PDE5, that the
sildenafil reduces the overall motions of the protein as is expected of an inhibitor.
Interestingly, the γ-bound system showed very little motion, but sampled a space not
explored as much as in the apo or sildenafil bound systems. The RMSF data backs this
up, as the fluctuations in some regions for the γ-bound system are higher than in the apo
system (Figure 5b).

A

B

C
H-loop

Res 678 to
710

M-loop

Figure 6: A) Principal component analysis of PDE6 apo, PDE6 with sildenafil bound, and PDE6
with γ-subunit bound. B) Principal analysis of PDE6 apo, PDE6 N661A, and PDE6 N661S. C)
RMSF of PDE6 apo, PDE6 with sildenafil bound, and PDE6 with γ-subunit bound

All of this analysis is good validation of the methods used and allowed us to
proceed with analyzing the data from the PDE6 systems (Figure 6). The PCA of the apo
system shows large sampling, whereas the sildenafil bound system samples a smaller and
17

different area of the principal component space (Figure 6A). The γ-bound subunit shows
a very small sampling of the same PC space that the apo system samples (Figure 6A).
Looking at the mutations, the PCA shows that both significantly change the motions of
PDE6 in the PC space (Figure 6B). That single point mutations so significantly change
the motions of PDE6 is a reflection of the importance of that residue as well as of those
mutations in the development of retinitis pigmentosa.

H- and M-Loop Distances and Dynamics

A

B

Figure 7: a) H- and M-loop distances were calculated as the distance between residues S668 and
L797 (highlighted in the figure) for each system b) H- and M-loop distances for the apo systems.

The H- and M-loop distances were calculated as the distance between the ends of
the two loops (Figure 7). Over the course of the apo simulations, PDE5 showed variable
distance between the loops, with the distance ranging from ~12 to ~30 Å. PDE5/6
showed a constant distance of ~7 Å before shifting up to ~12 Å. PDE6 meanwhile
showed a constant distance of ~7 Å. All of the other PDE6 systems also showed a
constant distance of ~7 Å.
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The variable PDE5 distance may reflect an equilibration process from the crystal
structure or more interestingly may be highlighting that the loops are very dynamic. The
constant PDE6 distance mirrors the experimental data from PDE5/6 and could indicate
that PDE5/6’s H- and M-loop distance may be representative of PDE6’s.
The RMSFs for the apo systems highlighted that the PDE5 and PDE6 H- and Mloops were very flexible, indicating that they are dynamic (Figures 4 and 6C). The RMSF
of apo PDE5/6 however showed very low flexibility in the residues that make up the Hloop as well as lower flexibility in the M-loop as compared to in PDE5 and PDE6 (Figure
5B). Also, the RMSFs of PDE6 show a third region of high flexibility between the H- and
M-loops (residues 678 to 710). This new region showing high flexibility may indicate it
is important in the dynamics of PDE6. Interestingly, although the RMSF in the H- and
M-loops in PDE6 is high, the distance between the loops is still constant. A reasonable
conclusion to reconcile these two data is that the motions of the two loops are correlated,
which can be tested by the cross-correlational analysis.

Cross-Correlational Analysis

A

B

Figure 8: a) Cross-correlational analysis of PDE6 apo system. X and Y axes are residue numbers,
and colored regions show correlation (blue) or anti-correlation (purple) for those residues. b) 3D
19

representation of the anti-correlations between residues in PDE6 apo shown as blue lines that
connect the anti-correlated residues.

The Bio3D cross-correlational analysis showed very little correlations for all of
the PDE5 and PDE5.6 systems. The system that showed the most correlations was apo
PDE6 (Figure 8). The H- and the M-loops show strong correlations. More interestingly,
both loops show correlations with the same ‘new region’ that showed high flexibility.
This could be an indication of a potential allosteric region of regulation that has not been
previously studied.

Discussion
As mentioned, the validation data was strong enough to be able to confirm that
the methods and structures used would give accurate data from stable simulations. The
initial aim of this work was to understand in more depth the H- and M-loop distance and
dynamics.
The H- and M-loop distances in PDE6 systems being small and stable agrees with
the structural information from the crystal structure of PDE5/6, which suggested a
smaller H- and M-loop distance than in PDE5. The consistency of this small distance
across the sildenafil and γ-bound systems is a good indication that this structural feature
is not an artifact of any one system but a robust feature of the protein. The PDE5 H- and
M-loop distance varying so wildly may be the structural explanation for the lower rate of
cGMP hydrolysis. A small distance may somehow aid in binding of cGMP for
hydrolysis, so the stable small distance seen PDE6 yields high efficiency while the
varying, unstable distance in PDE5 yields lower efficiency.
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The previously noted correlation between the H- and M-loops are not unexpected,
the RMSFs showed that the loops were very flexible/mobile and the distance between the
loops stayed constant. The only way to reconcile these facts would be if the loops were
moving in coordination together, i.e. if there motions of the loops were correlated. The
confirmation of this correlation through the cross-correlational analysis neatly ties
together all of these data. That these correlations don’t exist in the PDE5 or PDE5/6
systems may mean that the two loops behave differently in PDE6. The correlation that
exists between the two loops in PDE6 may somehow contribute to increased affinity for
cGMP and the resulting higher rate of hydrolysis of cGMP in PDE6.

Figure 9: Motions of the first principal component for PDE6 apo.

Some key data pieces may explain the structural reasons for the difference in
functionality in PDE6 and PDE5. That the previously mentioned third region (residues
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678 to 710, tentatively called the KM region) with high fluctuations seen in the RMSF
also showed correlations with both the H- and M-loops indicated that it may be an
allosteric region of regulation. The motions of the first principal component (Figure 9),
which comprise 31.4% of the motion, also supports this idea. The first principal
component shows a ‘breathing’ motion with the H- and M-loops moving together
towards the catalytic pocket and the KM region moving up towards the catalytic pocket.
The motions of the first principal component for PDE5 apo do not show this same
breathing motion (Supplementary Figure 2). Our hypothesis is that this concerted motion
helps provide access and possibly recruit cGMP to the catalytic pocket to allow
hydrolysis, which results in the high activity observed in PDE6. The lack of fluctuations
and correlations in the corresponding residues in PDE5 and PDE5/6 along with the lack
of the breathing motion in the first principal component all has lead us to hypothesize that
in these enzymes, cGMP diffuses passively to the catalytic pocket without guidance from
the two loops and the KM region.

A

B

Figure 10: a) PDE6 apo with H-loop highlighted in green, M-loop in yellow, and KM region in
red. b) PDE6 with the γ-subunit bound. γ-subunit shown in space filling representation,
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highlighting that it blocks the catalytic pocket and interferes with interactions between the H- and
M-loops and the KM region.

The KM region may also explain the need for the γ-subunit. As a key regulator of
the eyesight signaling pathway, regulation of PDE6 itself is key. When PDE6 is active, it
is necessary for the enzyme to hydrolyze cGMP quickly so that the signal can be passed
on quickly and vision can occur almost instantly. Our hypothesis is that the KM region
works in concert with the H- and M-loops to cause active transport of cGMP to the
catalytic pocket for hydrolysis. When there is no light, there should be no signal
propagation and no vision, so PDE6 should be completely off. The γ-subunit not only
blocks access to the catalytic pocket, it also disrupts any allosteric interactions between
the H- and M-loops and the KM region by physically coming between the regions (Figure
10). The blocking of the H- and M-loops and KM region interactions prevents any active
diffusion to the catalytic pocket in addition to blocking access to the pocket.
All of the data strongly suggests that the KM region is an allosteric region of
regulation. This information can hopefully be used by experimentalists to create a new
chimera that more accurately represents PDE6 and its functionality. The KM region may
also be used as an allosteric therapeutic target for retinitis pigmentosa or other diseases in
which PDE6 is implicated.
The data from these simulations suggests that the current PDE5/6 model may be a
poor experimental model of PDE6. As mentioned, the residues that correspond to the KM
region did not show high fluctuations or correlations in the chimera. In addition, the
entire cross-correlational graph for the chimera showed almost no correlations across all
the residues. That the H- and M-loops and the KM region all lacked correlations in the
chimera and had strong correlations in PDE6 shows that the two enzymes have very
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different structural dynamics. This is further reinforced by the fact that when the γsubunit was bound to PDE5/6 in the simulations, the fluctuations in the RMSF increased
for most of the residues, whereas in PDE6 there was reduced flexibility throughout the
protein. All of this in conjunction with the fact that PDE5/6 hydrolyzes cGMP much
slower than PDE6 suggests the large difference in the function of the two enzymes is due
to these structural differences. By substituting in the residues for the KM region of PDE6
into PDE5, experimentalists may be able to create a chimera that better models PDE6 in
its hydrolysis of PDE6 and inhibition by the γ-subunit.
The mutated PDE6 systems showed vary different sampling in the principal
component space and had reduced correlations. The two mutations studied are both
located on the H-loop on one of the residues closest to the KM region (ASN661),
indicated that the mutations may potentially be disrupting the interactions between the Hloop and the KM region and that this disruption of the interactions is what causes such a
radical change in the motions of mutated PDE6 in principal component space. It is
possible that after further study of the KM region and learning more about its functional
significance that it may be used as a therapeutic target to treat retinitis pigmentosa.

Future Directions
Although the data from this simulation study is very promising, there is quite a lot
more work to be done in understanding PDE6 and its structure-function relationship.
Preliminary work has been done in modeling and simulating a new chimera with the KM
region residues from PDE6 substituted in (a gain of function experiment) and a PDE6
model with the KM region residues from PDE5 substituted in (a loss of function
experiment). Over the course of 100ns, the gain of function chimera showed increased
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correlations and the loss of function PDE6 showed loss of correlations. Although this is
promising, more analyses and simulations need to be run to confidently say that
substituting in the PDE6 KM region into PDE5/6 creates a chimera that better models
PDE6.
More work is also necessary in understanding exactly what occurs in the mutated
PDE6 simulations. Do the mutations directly disrupt the H-loop-KM region allosteric
interactions or are there long range differences that cause the changes in the motions in
principal component space? If there is a direct disruption of interactions, which residues
are key to the functional interactions? And how could the KM region potentially be
targeted for therapeutic drug design? Along the same lines, performing ligand
binding/unbinding simulations could help us further understand how the correlated
motions in PDE6 facilitate catalysis. This may help to understand the interactions
between the H- and M-loops and the KM region in PDE6 and how they differ from those
same interactions in PDE5 and the chimera. Metadynamics is one method that could be
used to run simulations in which the ligand (cGMP or sildenafil) is pulled out of the
catalytic pockets of PDE5 and PDE6 in an unbiased direction. By observing the pathway
that the ligand unbinds, we could evaluate if there are different pathways taken between
PDE5 and PDE6 that may relate the catalytic efficiency and degree of cooperativity
within the different enzyme. The binding pathway could be ‘reverse engineered’ and
insight could be gained into the structural differences in how the enzymes bind ligands.
Ongoing work is being done to validate the H- and M-loop distances calculated
from the 100ns simulations. For each system, 300ns simulations with three different
starting velocities are being run. These multiple and longer simulations should give
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enough data to validate the H- and M-loop distances and other results reached from all of
the 100ns simulations.

Conclusions
The simulations done show that the PDE5/6 H- and M-Loop distance observed
experimentally may be indicative of actual PDE6 H- and M-Loop distance, with
validation work ongoing (Supplementary Figure 3). We believe that the differences in HM loop dynamics may relate to different ligand binding pathways and higher catalytic
efficiency for PDE6. The KM region (residues 678 to 710) discovered through this work
may explain the need for a regulatory subunit (γ) in PDE6, as the PDE6-γ binding
location would potentially disrupt the correlations between KM and H-M regions.
Finally, PDE5/6 may be an incomplete model for PDE6 because the residues that
correspond to the KM region in PDE5/6 did not show high fluctuations in RMSF data or
correlations with the H- and M-Loops in dynamic cross correlation data. Using this
information, a chimera that more accurately models PDE6 may warrant development.
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Supplementary Figure 1: A) Cross-correlational analysis of PDE5 apo system. B) Crosscorrelational analysis of PDE5/6 apo system

Supplementary Figure 2: Motions of the first principal component of PDE5 apo. Comprises
32.7% of the motions of the protein during the simulation.
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Supplementary Figure 3: Histogram of PDE5 and PDE6 apo H- and M-loop distances after
preliminary 300ns simulation of each system.
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